Pharmafile Logo

Spoon full of sugar

EU flag

EC approves Otsuka and Astex’s Inaqovi for acute myeloid leukaemia

Inaqovi is the first oral hypomethylating agent approved for this patient population

- PMLiVE

CSL Seqirus highlights impact of flu vaccines on reducing strain on healthcare resources

Flu vaccines for older adults in France could reduce hospitalisations by up to 30%

- PMLiVE

Moderna’s XBB.1.5-adapted COVID-19 vaccine receives MHRA approval

The vaccine has been updated to target the currently circulating XBB.1.5 Omicron variant

- PMLiVE

Almirall receives CHMP recommendation for lebrikizumab in atopic dermatitis

The drug has been recommended as a treatment option for adult and adolescent patients

- PMLiVE

GSK’s Ojjaara receives FDA approval to treat myelofibrosis patients with anaemia

Myelofibrosis is a rare blood cancer affecting approximately 25,000 patients in the US

- PMLiVE

NHS bookings for COVID-19 vaccinations open as winter programme starts early

Millions of people in England are now eligible to receive flu and COVID-19 vaccines

- PMLiVE

Clinigen launches educational programme for rare disease patients and organisations

The NaviGATE programme will aim to empower patients and provide navigational support

- PMLiVE

PM Society announces 2023 Digital Award winners

OPEN Health takes three Golds while Astellas Pharma UK tops client leader board

- PMLiVE

Point.1 – HCP data with purpose and perception

By Phil Streit and Sarah Price

- PMLiVE

Havas Lynx launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Havas Lynx

World-environmental-health-day-2023

World Environmental Health Day 2023

As a business in the health industry, we're always striving to do what we can to help improve the health and well-being of people worldwide.

Mednet

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links